Industry News
Biotechnology Industry News
Overcoming resistance to cancer immunotherapy by targeting garbage-cleaning cells in tumors
Overcoming resistance to cancer immunotherapy by targeting garbage-cleaning cells in tumors aliu Wed, 08/11/2021 - 12:05
Purdue subsidiary buys non-opioid pain prospect from PureHealth
Purdue subsidiary buys non-opioid pain prospect from PureHealth ntaylor Wed, 08/11/2021 - 08:10
Purdue subsidiary buys non-opioid pain prospect from PureTech Health
Purdue subsidiary buys non-opioid pain prospect from PureTech Health ntaylor Wed, 08/11/2021 - 08:10
BioCryst scraps $200M offering after seeing share price slide
BioCryst scraps $200M offering after seeing share price slide ntaylor Wed, 08/11/2021 - 06:59
Eli Lilly takes its trial work on the road, literally, as it loads up RVs to broaden its study reach
Eli Lilly takes its trial work on the road, literally, as it loads up RVs to broaden its study reach badams Wed, 08/11/2021 - 04:26
Healthy ‘beige’ fat protects brain from dementia in mouse models
Healthy 'beige' fat protects brain from dementia in mouse models klahucik Tue, 08/10/2021 - 11:40
Visus raises $20M ahead of data drop on rival to AbbVie prospect
Visus raises $20M ahead of data drop on rival to AbbVie prospect ntaylor Tue, 08/10/2021 - 08:46
FDA finds fault with Axsome’s depression filing, sinking stock
FDA finds fault with Axsome's depression filing, sinking stock ntaylor Tue, 08/10/2021 - 07:45
Pragmatism prevails for Dicerna as it looks to out-license the sales work for mixed bag nedosiran
Pragmatism prevails for Dicerna as it looks to out-license the sales work for mixed bag nedosiran badams Tue, 08/10/2021 - 03:48
Stopping cancer cells by blocking a growth-promoting protein and reactivating protective p53
Stopping cancer cells by blocking a growth-promoting protein and reactivating protective p53 arlene.weintraub Mon, 08/09/2021 - 09:24
Merck’s Vaxneuvance lead departs to help develop rival vaccine at Affinivax
Merck's Vaxneuvance lead departs to help develop rival vaccine at Affinivax ntaylor Mon, 08/09/2021 - 08:07
Merck’s pediatric Vaxneuvance lead departs to help develop rival vaccine at Affinivax
Merck's pediatric Vaxneuvance lead departs to help develop rival vaccine at Affinivax ntaylor Mon, 08/09/2021 - 08:07
Philip Morris’ biopharma addiction ramps up, as heart attack biotech OtiTopic joins cigarette maker on ‘Beyond Nicotine’ journey
Philip Morris' biopharma addiction ramps up, as heart attack biotech OtiTopic joins cigarette maker on 'Beyond Nicotine' journey badams Mon, 08/09/2021 - 07:48
AbbVie, on a Mission, picks Alzheimer’s, Parkinson’s targets, as partner nabs $20M
AbbVie, on a Mission, picks Alzheimer's, Parkinson's targets, as partner nabs $20M ntaylor Mon, 08/09/2021 - 05:42
Mixed pivotal data on Dicerna rival to Alnylam drug sink stock
Mixed pivotal data on Dicerna rival to Alnylam drug sink stock ntaylor Fri, 08/06/2021 - 05:07
Dicerna’s stock sinks after its Alnylam rival shows mixed data, stymieing approval filing
Dicerna's stock sinks after its Alnylam rival shows mixed data, stymieing approval filing ntaylor Fri, 08/06/2021 - 05:07
Study of dogs and cats sheds light on key immune pathways
Study of dogs and cats sheds light on key immune pathways klahucik Thu, 08/05/2021 - 16:24
Sierra raids the bargain bin again, picking up AstraZeneca cancer drug to pair with Gilead castoff
Sierra raids the bargain bin again, picking up AstraZeneca cancer drug to pair with Gilead castoff ntaylor Thu, 08/05/2021 - 11:11
Valneva, racing Merck for a PRV, hits goal in vaccine phase 3
Valneva, racing Merck for a PRV, hits goal in vaccine phase 3 ntaylor Thu, 08/05/2021 - 06:47
Valneva, racing Merck for a priority review voucher, exceeds protection goal in phase 3 chikungunya vaccine trial
Valneva, racing Merck for a priority review voucher, exceeds protection goal in phase 3 chikungunya vaccine trial ntaylor Thu, 08/05/2021 - 06:47